Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 30, 2009Arthritis Care & Research

Successful treatment of reactive arthritis with a humanized anti–interleukin‐6 receptor antibody, tocilizumab

View Full Paper
Ask AI
Bookmark
Share

Authors

TTToshio TanakaDaikin (United States)YKYusuke KuwaharaDaiichi-Sankyo (Japan)YSYoshihito ShimaThe University of Osaka

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tanaka et al. (2009) studied this question.

synapsesocial.com/papers/6a91479980800acc7233fa02https://doi.org/10.1002/art.24899
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Management of reactive arthritis2004 · 25 citations
  2. 2Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: An open-label trial2005 · 86 citations
  3. 3Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody2009 · 30 citations
  4. 4Treatment of reactive arthritis with infliximab2003 · 60 citations